In Madhya Pradesh, Corona's havoc continues to grow. Doctors and scientists are busy making medicines at their level to deal with the coronavirus. Meanwhile, good news has come from Bhopal. AIIMS of Bhopal, which has become a hotspot of coronavirus, is going to conduct a clinical trial of immuno-modulator drug 'Mycobacterium-W' to protect against corona. AIIMS Bhopal will soon conduct a clinical trial of the immuno-modulator drug 'Mycobacterium-W'. This medicine is in the form of an injection. Clinical trials will be conducted on severely debilitated patients infected with the corona so that the effect and safety standards of this vaccine can be evaluated.
"China has to answer some questions," says British Foreign Secretary Dominic Raab
AIIMS has issued an authorized statement that the immuno-modulator injection named Microbacterium-W has been manufactured by the pharmaceutical manufacturer Cadila Pharmaceuticals of Ahmedabad (Gujarat). Clinical trials have been approved by both the USA and India's top health research bodies FDA (US-Food and Drug Administration) and ICMR.
CM Yogi orders to take strict against people who attacked Medical team in Moradabad
Significantly, the period of three months has been fixed for this research study. According to Dr Sarman Singh, the trial process will begin within the next one week. It will be used on 100 patients. For this, Covid-19 positive patients will be admitted to AIIMS soon.
